Navigation Links
Medrio Strengthens Executive Management Team with Addition of Christina Hughes as COO

Medrio is pleased to announce the addition of Chief Operating Officer, Christina Hughes, to its executive leadership team.

As a market leader in solutions for EDC, Direct Data Capture and eCOA, Medrio’s integrated technology solutions allow growth-stage biotech and pharma companies to reduce timelines and improve quality with real-time data capture. In her role as COO, Christina will be responsible for developing a world class Customer Success organization focused on accelerating the delivery of Medrio’s technology solutions.

Christina brings over 20 years of experience in health care technology. She most recently was a Vice President at ERT, where she was responsible for ERT’s global service delivery organization across multiple service lines. Prior to ERT, Christina worked for AiCure and Bracket (now Signant Health) in sales and marketing, business development operations, and client services. Christina was named as one of PharmaVOICE’s top 100 most influential people in the life sciences industry in 2016.

“Christina brings tremendous experience and vision to our team and will be a great asset as we continue to scale our organization to meet the needs of our growth stage customers,” said Mike Novotny, founder and chief executive officer of Medrio. “Furthermore, Customers First is one of our guiding principles at Medrio and I am thrilled we can leverage Christina’s extensive experience leading professional services organizations to fuel our next stage of growth.”

“I am excited to join a company with a world-class technology platform like Medrio’s. I look forward to helping our clients accelerate their study timelines and maximize the value from Medrio’s solutions for Real World data capture,” commented Christina Hughes, regarding her new role as Medrio COO.

Christina holds a Master of Business Administration from the University of Pennsylvania’s The Wharton School and a Bachelor of Science from Yale University.

About Medrio
Medrio offers software-based eClinical solutions, providing clinical researchers with the tools necessary to accelerate research, eliminate hurdles, and maximize return on investment. Partnering with sponsors and CROs across all phases of research in pharma, biotech, medical device, and diagnostics, Medrio supports its clients along their journey to medical discovery.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology news :

1. Quartesian LLC Executes Multi-Year Enterprise Agreement with Medrio, Securing Access to Innovative eClinical Functionality and Support Services
2. MMS Holdings Leverages Medrio to Accelerate Clinical Trial Process for Study Sponsors Through New Contract
3. Hoyos Labs Strengthens Scientific Team with Two New Hires Prior to New Technology Debut at CES 2014
4. Markets Poised for Healthy 2014 as Biometrics Makes Strides in Technology Sector - Company Strengthens Board with Industrys Top Leaders
5. Study strengthens link between neonicotinoids and collapse of honey bee colonies
6. Phase 3 study strengthens support of ibrutinib as second-line therapy for CLL
7. Clinlogix Strengthens Partnership With eClinical Technology Leader MedNet Solutions
8. RG+A Strengthens Its Executive Team by Appointing New Chief Executive Officer and President/Chief Operating Officer
9. Five-Time World Champion Boxer Vinny Paz Shares Thoughts About Upcoming Movie, Bleed For This (Executive Produced by Martin Scorsese and Starring Miles Teller), Boxing, God and Whats Next
10. Five-Time World Champion Boxer Vinny Paz Shares Thoughts About Upcoming Movie, "Bleed For This" (Executive Produced by Martin Scorsese and Starring Miles Teller), Boxing, God and Whats Next
11. C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer
Post Your Comments:
(Date:3/20/2020)... Conn. (PRWEB) , ... March 20, 2020 , ... ... the development of human embryonic stem cell (ESC) derived mesenchymal stem cells (hES-MSC), ... T-MSC) for the treatment of neurological, autoimmune, and rare orphan diseases, today announced ...
(Date:3/13/2020)... ... March 13, 2020 , ... According to ... can cause conjunctivitis and possibly be transmitted by aerosol or direct contact with ... wearers should take special precautions to avoid contracting the coronavirus. Touching the eyes ...
(Date:3/10/2020)... ... March 10, 2020 , ... Cytonus Therapeutics ... Dr. Narasimhan is Senior Vice President of Strategic Initiatives, Portfolio Innovation and Investor ... Directors of Cytonus, we are extremely pleased to welcome Manisha Narasimhan as an ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... ... 2020 , ... Red Nucleus, a leading provider of strategic ... opening of a new office in Tokyo, Japan. The new office will be ... the new office in response to customer requests for regional coverage. Customers headquartered ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... results from a long-term follow-up clinical study of outpatient L4-L5 lumbar interspinous ... LLC). Unlike extension block design, the Inspan device fixates the spine to ...
(Date:2/10/2020)... ... February 10, 2020 , ... R3 Medical Training announced it ... 13-14th, 2020 in Las Vegas. The course is hands on involving real patients and ... past few years, the Comprehensive Stem Cell Training Course has received rave reviews from ...
(Date:2/5/2020)... BEACH, Fla. (PRWEB) , ... February 05, 2020 , ... ... an annual observance, sponsored by The National Organization for Rare Disorders (NORD), to raise ... patients’ lives ( ). The Balancing Act’s “Behind The Mystery” rare ...
Breaking Biology Technology: